Europe Dengue Vaccines Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Dengue Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Dengue Vaccines Market Segmentations:

    By Player:

    • Sanofi

    • Takeda Pharmaceutical

    By Type:

    • CYD-TDV

    • Tak-003

    • Others

    By End-User:

    • Hospitals

    • Government Institutes

    • Non-Governmental Organizations (NGOs)

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dengue Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Dengue Vaccines Market Size and Growth Rate of CYD-TDV from 2014 to 2026

    • 1.3.2 Europe Dengue Vaccines Market Size and Growth Rate of Tak-003 from 2014 to 2026

    • 1.3.3 Europe Dengue Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Dengue Vaccines Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.2 Europe Dengue Vaccines Market Size and Growth Rate of Government Institutes from 2014 to 2026

    • 1.4.3 Europe Dengue Vaccines Market Size and Growth Rate of Non-Governmental Organizations (NGOs) from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Dengue Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Dengue Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of CYD-TDV

      • 3.4.2 Market Size and Growth Rate of Tak-003

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Dengue Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Dengue Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hospitals for Construction

      • 4.4.2 Market Size and Growth Rate of Government Institutes for Construction

      • 4.4.3 Market Size and Growth Rate of Non-Governmental Organizations (NGOs) for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Dengue Vaccines Production Analysis by Top Regions

    • 5.2 Europe Dengue Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe Dengue Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Dengue Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Dengue Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Dengue Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Dengue Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Dengue Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Dengue Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Dengue Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Dengue Vaccines Landscape Analysis

    • 7.1 Germany Dengue Vaccines Landscape Analysis by Major Types

    • 7.2 Germany Dengue Vaccines Landscape Analysis by Major End-Users

    8. UK Dengue Vaccines Landscape Analysis

    • 8.1 UK Dengue Vaccines Landscape Analysis by Major Types

    • 8.2 UK Dengue Vaccines Landscape Analysis by Major End-Users

    9. France Dengue Vaccines Landscape Analysis

    • 9.1 France Dengue Vaccines Landscape Analysis by Major Types

    • 9.2 France Dengue Vaccines Landscape Analysis by Major End-Users

    10. Italy Dengue Vaccines Landscape Analysis

    • 10.1 Italy Dengue Vaccines Landscape Analysis by Major Types

    • 10.2 Italy Dengue Vaccines Landscape Analysis by Major End-Users

    11. Spain Dengue Vaccines Landscape Analysis

    • 11.1 Spain Dengue Vaccines Landscape Analysis by Major Types

    • 11.2 Spain Dengue Vaccines Landscape Analysis by Major End-Users

    12. Poland Dengue Vaccines Landscape Analysis

    • 12.1 Poland Dengue Vaccines Landscape Analysis by Major Types

    • 12.2 Poland Dengue Vaccines Landscape Analysis by Major End-Users

    13. Russia Dengue Vaccines Landscape Analysis

    • 13.1 Russia Dengue Vaccines Landscape Analysis by Major Types

    • 13.2 Russia Dengue Vaccines Landscape Analysis by Major End-Users

    14. Switzerland Dengue Vaccines Landscape Analysis

    • 14.1 Switzerland Dengue Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland Dengue Vaccines Landscape Analysis by Major End-Users

    15. Turkey Dengue Vaccines Landscape Analysis

    • 15.1 Turkey Dengue Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey Dengue Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Dengue Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland Dengue Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway Dengue Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden Dengue Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland Dengue Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Dengue Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands Dengue Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Dengue Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Dengue Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia Dengue Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania Dengue Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Sanofi

      • 19.1.1 Sanofi Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Takeda Pharmaceutical

      • 19.2.1 Takeda Pharmaceutical Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    The List of Tables and Figures (Totals 120 Figures and 183 Tables)

    • Figure Product Picture

    • Figure Dengue Vaccines Market Size and Growth Rate of CYD-TDV Market, 2015 - 2026 (USD Million)

    • Figure Dengue Vaccines Market Size and Growth Rate of Tak-003 Market, 2015 - 2026 (USD Million)

    • Figure Dengue Vaccines Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Dengue Vaccines Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Dengue Vaccines Market Size and Growth Rate of Government Institutes from 2014 to 2026

    • Figure Dengue Vaccines Market Size and Growth Rate of Non-Governmental Organizations (NGOs) from 2014 to 2026

    • Figure Germany Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Dengue Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Dengue Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Dengue Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Dengue Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Dengue Vaccines by Different Types from 2014 to 2026

    • Figure Dengue Vaccines Market Size and Growth Rate of CYD-TDV Market, 2015 - 2026 (USD Million)

    • Figure Dengue Vaccines Market Size and Growth Rate of Tak-003 Market, 2015 - 2026 (USD Million)

    • Figure Dengue Vaccines Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Dengue Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Dengue Vaccines by Different End-Users from 2014 to 2026

    • Figure Dengue Vaccines Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Dengue Vaccines Market Size and Growth Rate of Government Institutes from 2014 to 2026

    • Figure Dengue Vaccines Market Size and Growth Rate of Non-Governmental Organizations (NGOs) from 2014 to 2026

    • Table Europe Dengue Vaccines Production by Major Regions

    • Table Europe Dengue Vaccines Production Share by Major Regions

    • Figure Europe Dengue Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe Dengue Vaccines Consumption by Major Regions

    • Table Europe Dengue Vaccines Consumption Share by Major Regions

    • Table Germany Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table UK Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table France Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Dengue Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Dengue Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Dengue Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Dengue Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Germany Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table UK Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table France Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table France Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table France Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Italy Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Spain Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Poland Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Russia Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dengue Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dengue Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dengue Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Dengue Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Sanofi Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Product benchmarking

    • Table Sanofi Strategic initiatives

    • Table Sanofi SWOT analysis

    • Table Takeda Pharmaceutical Profiles

    • Table Takeda Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Takeda Pharmaceutical Product benchmarking

    • Table Takeda Pharmaceutical Strategic initiatives

    • Table Takeda Pharmaceutical SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.